SCPS
Income statement / Annual
Last year (2022), Scopus BioPharma Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Scopus BioPharma Inc.'s net income was -$11.61 M.
See Scopus BioPharma Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$2.68 M
|
$15.02 M
|
$7.42 M
|
$463,111.00
|
$277,539.00
|
| General & Administrative
Expenses |
$9.03 M
|
$12.61 M
|
$2.73 M
|
$2.23 M
|
$408,425.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.03 M
|
$12.61 M
|
$2.73 M
|
$2.23 M
|
$408,425.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$11.71 M |
$27.63 M |
$10.16 M |
$2.69 M |
$685,964.00 |
| Cost And Expenses |
$11.71 M |
$27.63 M |
$10.16 M |
$2.69 M |
$685,964.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$774,679.00 |
$706,446.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1,728.00
|
$1,500.00
|
$1,440.00
|
$664.00
|
$161,141.00
|
| EBITDA |
-$11.71 M
|
-$27.63 M
|
-$10.15 M
|
-$2.69 M
|
-$685,964.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$0.00
|
$681,210.00
|
-$706,446.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$11.71 M |
-$26.95 M |
-$10.86 M |
-$2.69 M |
-$685,964.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$105,050.00 |
$774,679.00 |
$706,446.00 |
$1.00 |
-$847,105.00 |
| Net Income |
-$11.61 M |
-$27.73 M |
-$11.57 M |
-$2.69 M |
-$685,964.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.55 |
-1.61 |
-0.87 |
-0.18 |
-0.0458 |
| EPS Diluted |
-0.55 |
-1.61 |
-0.87 |
-0.18 |
-0.0458 |
| Weighted Average Shares
Out |
$21.09 M
|
$17.25 M
|
$13.36 M
|
$14.98 M
|
$14.98 M
|
| Weighted Average Shares
Out Diluted |
$21.09 M
|
$17.25 M
|
$13.36 M
|
$14.98 M
|
$14.98 M
|
| Link |
|
|
|
|
|
